- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07692373
Groningen Meander Walking Test in Older Adults With Balance Problems (GMWT-OA)
Test-Retest Reliability and Construct Validity of the Groningen Meander Walking Test in Older Adults With Self-Reported Balance Problems and/or a History of Falls
Descripción general del estudio
Estado
Condiciones
Descripción detallada
This observational cross-sectional study will evaluate the reliability and validity of the Groningen Meander Walking Test in older adults with self-reported balance problems and/or a history of falls. Participants aged 65 years or older will be recruited from the Orthopedics and Traumatology outpatient clinic of Ordu University Training and Research Hospital.
The Groningen Meander Walking Test will be administered in two assessment sessions to examine within-day and between-day test-retest reliability. Completion time and overstep score will be recorded. Construct validity will be assessed by comparing Groningen Meander Walking Test outcomes with established clinical measures of functional mobility, curved walking performance, balance, and concern about falling.
The study aims to determine whether the Groningen Meander Walking Test is a clinically useful assessment tool for advanced walking ability in older adults with balance problems and/or fall history.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Ordu
-
Altinordu, Ordu, Turquía (Türkiye), 52200
- Ordu university
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
Aged 65 years or older Self-reported balance problems during activities of daily living and/or a history of at least one fall within the previous 12 months Able to walk independently with or without a single walking aid Able to understand and follow verbal instructions Willing to provide written informed consent
Exclusion Criteria:
Presence of neurological, vestibular, visual, orthopedic, systemic, or medical conditions that may substantially affect gait or balance Acute lower-extremity injury or recent lower-extremity surgery Severe pain preventing completion of the walking or balance tests Cognitive impairment that may limit the ability to understand or follow test instructions Inability to walk independently without personal assistance Use of a rollator
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Older Adults With Balance Problems
Participants aged 65 years or older with self-reported balance problems and/or a history of falls within the previous 12 months will undergo clinical assessments, including the Groningen Meander Walking Test, Timed Up and Go Test, Figure-of-Eight Walking Test, Berg Balance Scale, and Falls Efficacy Scale-International.
No intervention will be administered.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Groningen Meander Walking Test Completion Time
Periodo de tiempo: Baseline and 3 to 7 days after baseline
|
Completion time of the Groningen Meander Walking Test will be recorded in seconds.
The mean of the start-to-end and end-to-start completion times will be used as the Groningen Meander Walking Test completion time.
A longer completion time indicates poorer advanced walking performance.
|
Baseline and 3 to 7 days after baseline
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Groningen Meander Walking Test Overstep Score
Periodo de tiempo: Baseline and 3 to 7 days after baseline
|
The number of times the participant's foot completely lands outside the marked pathway will be recorded.
Oversteps from the start-to-end and end-to-start directions will be summed.
A higher score indicates poorer stepping accuracy.
|
Baseline and 3 to 7 days after baseline
|
|
Timed Up and Go Test Completion Time
Periodo de tiempo: Baseline
|
Functional mobility will be assessed using the Timed Up and Go Test.
The time required to stand from a chair, walk 3 meters, turn, return to the chair, and sit down will be recorded in seconds.
A longer time indicates poorer functional mobility.
|
Baseline
|
|
Figure-of-Eight Walking Test Completion Time
Periodo de tiempo: Baseline
|
Curved walking performance will be assessed using the Figure-of-Eight Walking Test.
Completion time will be recorded in seconds, and a longer time indicates poorer advanced walking performance.
|
Baseline
|
|
Berg Balance Scale Score
Periodo de tiempo: Baseline
|
Functional balance will be assessed using the Berg Balance Scale.
Total scores range from 0 to 56, with higher scores indicating better balance performance and lower fall risk.
|
Baseline
|
|
Falls Efficacy Scale-International Score
Periodo de tiempo: Baseline
|
Concern about falling during daily activities will be assessed using the Falls Efficacy Scale-International.
Total scores range from 16 to 64, with higher scores indicating greater concern about falling.
|
Baseline
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: ELİF A POLAT, Assoc.Prof., Ordu university
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- ODU-SBFTR-AYGUNPOLAT-007
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .